Metraipolis › archive › dc_f64c78623919
PD-1 Inhibitor (Sintilimab) Combined With Chemotherapy as Neoadjuvant Therapy in Advanced Ovarian Cancer: A Case Report — Europe PMC PMID:42801091
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42801091
- DOI
- 10.1002/ccr3.73598
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T21:44:22.600Z
- SHA-256 of the archived text
ac1dbf3264d81808601ae073db0fe4a2883836328c8691c293f7d8f9bee929c2- Stable URL of this page
https://metraipolis.com/documento/dc_f64c78623919
How to cite
PD-1 Inhibitor (Sintilimab) Combined With Chemotherapy as Neoadjuvant Therapy in Advanced Ovarian Cancer: A Case Report — Europe PMC PMID:42801091 — Europe PMC (en), https://europepmc.org/article/MED/42801091 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f64c78623919 (Metraipolis archive dc_f64c78623919, sha256 ac1dbf3264d81808601ae073db0fe4a2883836328c8691c293f7d8f9bee929c2)
BibTeX
@misc{dcf64c78623919,
title = {PD-1 Inhibitor (Sintilimab) Combined With Chemotherapy as Neoadjuvant Therapy in Advanced Ovarian Cancer: A Case Report — Europe PMC PMID:42801091},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42801091},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f64c78623919; sha256 ac1dbf3264d81808601ae073db0fe4a2883836328c8691c293f7d8f9bee929c2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42801091. Agents can read the archived copy with the MCP tool read_document.